** 1. Virinchy is lead by high pedigree of professional management (mostly IIT & IIMs) team in both IT and HealthCare, Vish Kompella founder is itself IIT Madras **
**2. As for HealthCare from existing 800+ bed it intends to scale it up to 5000 beds by 2020 through public-privare partnership. **
**3. In Health care services(HCS), it plans whole ecosystem including hospitals, doctors, medical equipment, pharmacists and patients on a robust IT backbone. **
**4. VConnect (HCS) is venture where already 10 providers is onboard, 5000 rolled out & it plan to scale upto 60000 providers cum healthcare partner pan india by 2020 **
**5. On Product Arm, due to surge in US economy and cater demand it plan to rollout new data center in california this apart from existing one Atlanta US… **
**6. 150 Cr MCAP, growing through IP lead approach and with expected revenue about 490 Cr in FY18 and CAGR growth of 40%…
7. It won Emerging hospital of year by Times Health Care 2017, Below Financial does not include upside from HCS (companys big bet) and Virinchy learning vertical
**## Product Arm :
**With 15% CAGR,FY17=90 Cr, FY18=103,FY19=120 with blended 7% NPM ****
**IT Service:With 20% CAGR,FY17=135 Cr, FY18=162,FY19=195. with blended 7% NPM **
****HealthCare:Average Bed per day as per standard is about (Tier 1 City) 25000/Day,90 lac/Annum.**Virinchy will have for FY17=40 Cr, for FY18 will have 350+200=450 bed having around 400 Cr/Annum revenue.Since its 1st year we take 50% utilization **
hence revene to be 225 Cr, taking 10% EBITA,and 4% NPM, Net profit to be 9 Cr.In FY19 with 800 Bed with 75% Occupancy, revenue to be 540 Cr, with better utilization NPM to improve by 100 bps to 5%, hence 27 Cr.
Virinchi Limited, founded in 1990, is an IT Products & Services with has a headcount of over 365 resources working out of three Offshore Development Centers ODCs.IT clientele spread across globally in North America, Europe, Middle East, and Asia Pacific
Product Arm: 40% of revenue, 30% of EBIT contribution. With new 40 Cr order (Qfund on Cloud mode) for 3 years…this vertical to grow 15% CAGR for coming years…With revival in US Alternate finance will further enhance demand of Qfund and other related product…
, a 100% subsidiary of Virinchi Limited, is the Number One IT Vendor for deferred presentment industry in North America.It provides short-term loan related solutions like Payday Loan, Title Loan, Installment Loan, and Check Cashing for loan companies
~5% of all Short Term US Lending is through Qfund, loan processed at peak was about 230 $ million dollar/Month, It process $ 5 bn new loans p.a. And has 20,000 lender stores, incl. multi-billion listed companies
There are more Payday Outlets than McDonalds stores in the US.12 mn borrowers growing @ 7%. Since it is Heavily Regulated Industry lead, its is sticky business with good entry barrier.
is an innovative Point of Sale Credit Service IT Platform to provide lead sourcing, loan generation, machine learning underwriting, lender aggregation and integrated loan servicing for consumer loans
Instant mobile overdraft set-up and point-of-sale credit marketed as Downloadable Credit Card for US and India market
Ksoft IT services Arm:50% of revenue, 65% of EBIT , is fastest growing vertical with focus on cloud, analytic and other emerging tech. This vertical to grow 20% CAGR ahead, grown 6X in past 24 month.
KSoft arm of Virinchy provides IT solution in Financial Services, Healthcare and Life Sciences verticals and develop. Its key focus is Social, Analytic, Cloud, Mobility, package product service like SAP, Oracle etc…
IT Services revenue has grow 6 times in past 24 months, Competency built around High Quality Onshore and Offshore Personnel
Health Care Services…20% of revenue, last quarter it showed EBIT positive result with amalgation of Bristcone 200 bed hospital…
An 100% subsidiary, is in the process of setting up a 600 bed Greenfield super specialty hospital, spread over a total area of 350,000 Sq. Ft in up market of Hyderabad…
Phase I: 350 beds already commissioned ,Phase II: 150 beds to be commissioned by Q2 2017-18,Phase III : 100 beds with oncology to be commissioned by April 2018
11 Ots,62 OPDs across Eight Clusters,140 ICU beds also it has 3T functional MRI (best in class for Neuro imaging) and dual-energy, single-beat CT scan (best in class for cardiac imaging)
It is also merged with Bristlecone Hospitals Pvt. Ltd., a chain of hospitals with an aggregate bed capacity of 200 beds operating at two locations in Hyderabad. It has 80% average occupancy
Through Government and Private Partnerships it plans to add 100 -250 bed hospitals in district Headquarters and by 2020 it aims to have 5000 beds under its belt…
Virinchi Learning: its emerging vertical
NSDC funded project to upskill healthcare workers offering course like OT Technician, Anaesthesia Technician, Dialysis Technician, Diabetes Educator
Its State of Art Learning Management Solution for self learning and monitor performance and catering demand of Over 80,000 hospital staff to be trained and up skilled over next 10 years, Over 1000 staff in the next 12 months.
Virinchi Combinatorics and Systems Biology:
Its emerging vertical would be major contributor in margin for its high end analytics work in medical science…
A Multi-dimensional Time Based Patient data Analysis drive Evidence Based Medication, where it aims High Quality data for Clinical research, Integrated analytics delivery on Sophisticated Mobility Environment
Patient Cohort identification and monitoring, Phenotypes for targeted medication etc. This venture was establish last year in 2016 and company is betting big on this futuristic venture.
Its latest reserves stand at 114 Cr, Debt at 99 Cr (Includes 70 Cr debt raise for Virinchy Hospital last year), last 2 year OCF> PAT i.e. 34 Cr> 24 Cr respectively. In latest quarter it clocked highest EBITA margin of 21% in last 4 years…
To break even in Hospital is requires just 30% occupancy where as now Bristcone with 200 Beds is about 80% and 300 beds in started 2 month back in Banaras Hill company is getting good response…
Post amalgation with Bristcone promoter stake in Virinchy will increase to 49% …
Cons: Promoters integrity is not known and it is not giving dividend too…
Disclaimer: I am invested so my views may be biased